Frankfurt - Delayed Quote EUR

Spago Nanomedical AB (publ) (7UX.F)

0.0158

+0.0002

+(1.28%)

At close: May 14 at 3:29:02 PM GMT+2

Key Events

Loading Chart for 7UX.F

Previous Close 0.0156
Open 0.0158
Bid 0.0140 x --
Ask 0.0254 x --
Day's Range 0.0158 - 0.0158
52 Week Range 0.0118 - 0.0328
Volume 0
Avg. Volume 0
Market Cap (intraday) 6.142M
Beta (5Y Monthly) 1.86
PE Ratio (TTM) --
EPS (TTM) -0.0100
Earnings Date --
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Spago Nanomedical AB (publ), a clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden. Its products include SpagoPix (SN132D), an MRI contrast agent, which is under Phase I development stage for the treatment of breast cancer, and under Phase II development stage for the treatment liver and pancreas cancer, as well as offers Tumorad (SN201), a radionuclide therapy for treatment of advanced and metastatic cancer, under Preclinical development stage. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.

spagonanomedical.se

13

Full Time Employees

December 31

Fiscal Year Ends

Sector

Industry

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

7UX.F

0.00%

OMX Stockholm 30 Index (^OMX)

1.40%

1-Year Return

7UX.F

24.04%

OMX Stockholm 30 Index (^OMX)

4.36%

3-Year Return

7UX.F

91.23%

OMX Stockholm 30 Index (^OMX)

25.19%

5-Year Return

7UX.F

96.94%

OMX Stockholm 30 Index (^OMX)

70.53%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Spago Nanomedical AB (publ)

0.0158

+1.28%

Mkt Cap EUR 6.142M

Industry Biotechnology

IO Biotech, Inc.

0.9800

-2.00%

Mkt Cap 64.563M

Industry Biotechnology

4D Molecular Therapeutics, Inc.

3.1300

-4.28%

Mkt Cap 144.996M

Industry Biotechnology

Connect Biopharma Holdings Limited

0.7700

-2.41%

Mkt Cap 42.619M

Industry Biotechnology

Sangamo Therapeutics, Inc.

0.4380

-4.78%

Mkt Cap 100.387M

Industry Biotechnology

Corcept Therapeutics Incorporated

70.84

+0.35%

Mkt Cap 7.512B

Industry Biotechnology

ImmunityBio, Inc.

2.4900

-0.80%

Mkt Cap 2.215B

Industry Biotechnology

Valuation Measures

As of 5/13/2025

Market Cap

6.06M
Enterprise Value

3.09M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

31.12
Price/Book (mrq)

1.78
Enterprise Value/Revenue

17.63
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-45.07%
Return on Equity (ttm)

-87.21%
Revenue (ttm)

6.65M
Net Income Avi to Common (ttm)

-32.51M
Diluted EPS (ttm)

-0.0100

Balance Sheet and Cash Flow

Total Cash (mrq)

32.47M
Total Debt/Equity (mrq)

--
Levered Free Cash Flow (ttm)

-25.82M